Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
10 pending office actions • 3 clients • 10 examiners • 9 art units • 0 of 10 (0%) have an AI response strategy ready
Giordano Law LLC specializes in Biotechnology & Pharmaceuticals, having managed 133 career applications in this space. The firm has achieved a resolved allowance rate pct of 77.89. This allowance rate is coupled with an avg office actions per allowance of 3.0, which reflects the level of prosecution required to reach an allowance for their clients in this field.
The firm currently has 9 pending office actions under review. With 133 career applications on record, these 9 pending office actions represent the firm's current workload. The 77.89 resolved allowance rate pct and 3.0 avg office actions per allowance provide a benchmark for the outcomes and effort levels in their Biotechnology & Pharmaceuticals practice. These figures indicate the prosecution environment and the firm's experience in its technology area as it handles these active cases.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (20%) |
| §103 only | 2 (20%) |
| Double-patenting only | 1 (10%) |
| Double-patenting + other | 2 (20%) |
| Multi-statute (no §101) | 3 (30%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUTTER, GILLIAN A | 1 | 54.5% | +46.2% |
| OTTON, ALICIA L | 1 | 64.9% | +9.4% |
| NEAL, ALLISON MICHELLE | 1 | 19.5% | +27.0% |
| BATISTA, MARCOS | 1 | 81.9% | +16.4% |
| LIDDLE, JAY TRENT | 1 | 57.8% | +22.9% |
| LAZARO, DAVID R | 1 | 87.1% | +3.7% |
| HAN, ROBIN | 1 | 33.8% | +61.8% |
| KASSA, TIGABU | 1 | 36.7% | +27.9% |
| KOSTURKO, GEORGE W | 1 | 54.7% | +49.0% |
| KWON, JOHN SEUNGJAI | 1 | 45.7% | +19.3% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18786899 | Automatic Aftercall Directory And Phonebook Entry Advertising | BATISTA, MARCOS | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691840 | Intrauterine Contraceptive Device | HAN, ROBIN | 56d |
| 18920156 | AUTOMATIC AFTER CALL SURVEY AND CAMPAIGN-BASED CUSTOMER FEEDBACK COLLECTION PLATFORM | NEAL, ALLISON MICHELLE | — |
| 18707722 | SYSTEMS AND METHODS FOR LOTTERY GAME PLAY OVER MOBILE NETWORKS USING A MOBILE ACCOUNT | LIDDLE, JAY TRENT | — |
| 18707541 | METHODS AND SYSTEMS FOR EMOTIVE AND CONTEXTUAL MESSAGING | LAZARO, DAVID R | — |
| 18032749 | ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF | KASSA, TIGABU | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18691840 | Intrauterine Contraceptive Device | HAN, ROBIN | 56d |
| 19444750 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | HUTTER, GILLIAN A | — |
| 18920156 | AUTOMATIC AFTER CALL SURVEY AND CAMPAIGN-BASED CUSTOMER FEEDBACK COLLECTION PLATFORM | NEAL, ALLISON MICHELLE | — |
| 18786899 | Automatic Aftercall Directory And Phonebook Entry Advertising | BATISTA, MARCOS | — |
| 18707722 | SYSTEMS AND METHODS FOR LOTTERY GAME PLAY OVER MOBILE NETWORKS USING A MOBILE ACCOUNT | LIDDLE, JAY TRENT | — |
| 18032749 | ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF | KASSA, TIGABU | — |
| 17918386 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | KOSTURKO, GEORGE W | — |
| 17802078 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | KWON, JOHN SEUNGJAI | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Kolmar Korea | 5 |
| Onepin, Inc. | 4 |
| Sebela Vlc Limited | 1 |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| 1699 | 1 |
| 3625 | 1 |
| 3715 | 1 |
| 2455 | 1 |
| 3786 | 1 |
| 1619 | 1 |
| 1621 | 1 |
| 1615 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19444750 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | Hk Inno.N Corporation | HUTTER, GILLIAN A | 1625 | §102§103DP | Non-Final OA | — | Pending | Jan 09, 2026 |
| 19444665 | NOVEL PREPARATION CONTAINING BENZIMIDAZOLE DERIVATIVE | Hk Inno.N Corporation | OTTON, ALICIA L | 1699 | §102§103DPOther | Non-Final OA | — | Pending | Jan 09, 2026 |
| 18920156 | AUTOMATIC AFTER CALL SURVEY AND CAMPAIGN-BASED CUSTOMER FEEDBACK COLLECTION PLATFORM | Onepin, Inc. | NEAL, ALLISON MICHELLE | 3625 | §101DP | Non-Final OA | — | Pending | Oct 18, 2024 |
| 18786899 | Automatic Aftercall Directory And Phonebook Entry Advertising | Onepin, Inc. | BATISTA, MARCOS | DP | Non-Final OA | — | Pending | Jul 29, 2024 | |
| 18707722 | SYSTEMS AND METHODS FOR LOTTERY GAME PLAY OVER MOBILE NETWORKS USING A MOBILE ACCOUNT | Onepin, Inc. | LIDDLE, JAY TRENT | 3715 | §101§102§103 | Non-Final OA | — | Pending | May 06, 2024 |
| 18707541 | METHODS AND SYSTEMS FOR EMOTIVE AND CONTEXTUAL MESSAGING | Onepin, Inc. | LAZARO, DAVID R | 2455 | §102§103§112 | Non-Final OA | — | Pending | May 03, 2024 |
| 18691840 | Intrauterine Contraceptive Device | Sebela Vlc Limited | HAN, ROBIN | 3786 | §103§112 | Final Rejection | 56d | Pending | Mar 13, 2024 |
| 18032749 | ORALLY DISINTEGRATING TABLET COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND AND PREPARATION METHOD THEREOF | Hk Inno.N Corporation | KASSA, TIGABU | 1619 | §103§112 | Final Rejection | — | Pending | Apr 19, 2023 |
| 17918386 | PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND | Hk Inno.N Corporation | KOSTURKO, GEORGE W | 1621 | §103 | Final Rejection | — | Pending | Mar 27, 2023 |
| 17802078 | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION | Hk Inno. N Corporation | KWON, JOHN SEUNGJAI | 1615 | §103 | Non-Final OA | — | Pending | Aug 24, 2022 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial